Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - B.Braun; Medtronic
• Equity/Stock(s)/Options (Personal) - InnoRa GmbH